Last reviewed · How we verify

NCT06657820: OBPM:VOCOM

Optical Brain Pulse Monitor: Validation Of Cerebral Oximetry Monitoring (OBPM:VOCOM) Study.

Withdrawn NA Last updated 13 June 2025
What this trial tests

NA trial testing Hypoxia in healthy individuals in Hypoxia. Withdrawn.

Timeline
6 September 2025
Primary endpoint
30 December 2025
30 December 2025

Quick facts

Lead sponsorElliot Teo
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Start date6 September 2025
Primary completion30 December 2025
Estimated completion30 December 2025

Drugs / interventions tested

Conditions studied

Sponsor

Elliot Teo

Who can join

Adults 18 to 45, any sex, with Hypoxia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to calibrate and validate a cerebral oximeter product from Cyban Pty. Ltd. The study will involve comparing cerebral oximeter signals against reference arterial and jugular bulb blood gas measures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypoxia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06657820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing